Investors seeking stocks with high reward potential might want to consider this pharmaceutical company, oil and gas driller, and wind blade maker instead of wading into the high-risk penny stock market.
News & Analysis: Axsome Therapeutics
Despite already massive gains this year, shares of these drugmakers could keep on climbing.
These biotech stocks have at least quadrupled in just over six months this year.
This tiny biotech is racing toward a blockbuster drug launch.
Big-time investors have been buying shares of this small-cap biotech, e-commerce giant, and Canadian utility.
Don't miss out on these small-cap bargains.
Axsome Therapeutics, Flexion Therapeutics, and UroGen Pharma gave investors reasons for excitement.
This startup has rapidly developed two potential blockbusters that are close to the finish line, and hardly anybody's noticed yet.
AXSM earnings call for the period ending March 31, 2019.
These two companies are set to announce important business updates this month.